High Vista Strategies LLC Zymeworks Inc. Transaction History

High Vista Strategies LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$27.35 - $37.28 $696,112 - $948,850	-25,452 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$26.5 - $38.23 $117,925 - $170,123	4,450 Added 21.19%	25,452 $883,000
Q1 2021 May 17, 2021	BUY	$29.83 - $56.81 $190,733 - $363,243	6,394 Added 43.77%	21,002 $663,000
Q4 2020 Feb 16, 2021	SELL	$39.12 - $54.99 $66,582 - $93,592	-1,702 Reduced 10.44%	14,608 $690,000
Q3 2020 Nov 16, 2020	BUY	$29.21 - $46.58 $137,783 - $219,717	4,717 Added 40.69%	16,310 $760,000
Q2 2020 Aug 14, 2020	BUY	$33.67 - $40.0 $390,336 - $463,720	11,593 New	11,593 $418,000

296K

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $766M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on High Vista Strategies LLC with notifications on news.